Ascend constitutes medical advisory board for Acteev
December 30, 2020 - United States Of America
Ascend Performance Materials has constituted a medical advisory board comprising internationally recognised experts in the fields of PPE evaluation, viral pathology, epidemiology and infectious diseases, to provide counsel on its Acteev technology platform. The board will provide scientific review and advice on end applications of Acteev technology.
The experts in the board will help assess end applications of Acteev technology, including masks, filtration, fabrics and engineered plastics.
“This medical advisory board brings together some of the most distinguished researchers and medical experts from around the world,” said Dr. Vikram Gopal, Ascend’s senior vice president and chief technology officer. “We launched Acteev as a novel way to help fight the spread of the COVID-19 pandemic, and this team of advisors will be invaluable as we seek to rapidly develop Acteev to its full potential.”
The board includes C Raina MacIntyre, a professor of biosecurity at the University of New South Wales and head of the Global Biosecurity programme at the Kirby Institute for Infection and Immunity. She is director of Australia’s NHMRC Centre for Research Excellence in Integrated Systems for Epidemic Response.
Board also has - Karoll Cortez, an infectious disease physician at Greater Baltimore Medical Centre, Christopher McDevitt, an Australian Research Council Future Fellow and principal investigator in the Chemical Biology of Bacterial Pathogens Laboratory at the University of Melbourne, Department of Microbiology and Immunology, and Aartjan te Velthuis, an assistant professor at Princeton University, Department of Molecular Biology – as members.
The experts in the board will help assess end applications of Acteev technology, including masks, filtration, fabrics and engineered plastics.
“This medical advisory board brings together some of the most distinguished researchers and medical experts from around the world,” said Dr. Vikram Gopal, Ascend’s senior vice president and chief technology officer. “We launched Acteev as a novel way to help fight the spread of the COVID-19 pandemic, and this team of advisors will be invaluable as we seek to rapidly develop Acteev to its full potential.”
The board includes C Raina MacIntyre, a professor of biosecurity at the University of New South Wales and head of the Global Biosecurity programme at the Kirby Institute for Infection and Immunity. She is director of Australia’s NHMRC Centre for Research Excellence in Integrated Systems for Epidemic Response.
Board also has - Karoll Cortez, an infectious disease physician at Greater Baltimore Medical Centre, Christopher McDevitt, an Australian Research Council Future Fellow and principal investigator in the Chemical Biology of Bacterial Pathogens Laboratory at the University of Melbourne, Department of Microbiology and Immunology, and Aartjan te Velthuis, an assistant professor at Princeton University, Department of Molecular Biology – as members.